Australia-wide point prevalence survey of antimicrobial prescribing in neonatal units: How much and how good?

Pediatric Infectious Disease Journal

Volumn 34, Issue 8, 2015, Pages e185-e190

  Osowicki, Joshua ^a,b   Gwee, Amanda ^a,b   Noronha, Jesuina ^c   Britton, Philip N ^d   Isaacs, David ^d   Lai, Tony B ^d   Nourse, Clare ^e,f   Avent, Minyon ^g,h   Moriarty, Paul ^e   Francis, Joshua R ^i,j   Blyth, Christopher C ^i,k,l   Cooper, Celia M ^m   Bryant, Penelope A ^a,b,c,n  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c Monash Heart and Medical Centre   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g Mater Health   (Australia)

^h UNIVERSITY OF QUEENSLAND   (Australia)

ⁱ PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^j ROYAL DARWIN HOSPITAL   (Australia)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^l UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^m WOMEN S AND CHILDREN S HOSPITAL   (Australia)

ⁿ UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Antimicrobial stewardship; early onset sepsis; late onset sepsis; neonatal infections

Indexed keywords

ACICLOVIR; AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; CEFALEXIN; CEFOTAXIME; CLINDAMYCIN; FLUCLOXACILLIN; FLUCONAZOLE; GENTAMICIN; IMIPENEM; METRONIDAZOLE; NYSTATIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIMICROBIAL THERAPY; ARTICLE; AUSTRALIA; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; DRUG INDICATION; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL INFECTION; HUMAN; INAPPROPRIATE PRESCRIBING; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; SEPSIS; SOFT TISSUE INFECTION; SURGICAL INFECTION; TOTAL QUALITY MANAGEMENT; URINARY TRACT INFECTION; ANTIBIOTIC RESISTANCE; CROSS-SECTIONAL STUDY; NEWBORN INTENSIVE CARE; STATISTICS AND NUMERICAL DATA;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MALE; PRESCRIPTIONS; SEPSIS;

EID: 84937398816     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000719     Document Type: Article

References (37)

1. Du W, Warrier I, Tutag Lehr V, et al. Changing patterns of drug utilization in a neonatal intensive care population. Am J Perinatol. 2006; 23: 279-285
2. Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance-The need for global solutions. Lancet Infect Dis. 2013; 13: 1057-1098
3. World Health Organization. Antimicrobial resistance: global report on surveillance 2014. 2014: 257
4. Antibiotic Resistance Threats in the United States, 2013. Available at: http://www.cdc.gov/drugresistance/threat-report-2013/. In: Prevention CfDCa, ed. Atlanta, GA: Center for Disease Control and Prevention (CDC); 2013
5. Patel SJ, Saiman L. Principles and strategies of antimicrobial stewardship in the neonatal intensive care unit. Semin Perinatol. 2012; 36: 431-436
6. Tripathi N, Cotten CM, Smith PB. Antibiotic use and misuse in the neonatal intensive care unit. Clin Perinatol. 2012; 39: 61-68
7. Tzialla C, Borghesi A, Perotti GF, et al. Use and misuse of antibiotics in the neonatal intensive care unit. J Matern Fetal Neonatal Med. 2012; 25(Suppl 4): 35-37
8. Khadem TM, Dodds Ashley E, Wrobel MJ, et al. Antimicrobial stewardship: a matter of process or outcome?. Pharmacotherapy. 2012; 32: 688-706
9. Brett A, Bielicki J, Newland JG, et al. Neonatal and pediatric antimicrobial stewardship programs in Europe-defining the research agenda. Pediatr Infect Dis J. 2013; 32: e456-e465
10. Versporten A, Sharland M, Bielicki J, et al; ARPEC Project Group Members. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J. 2013; 32: e242-e253
11. Ceyhan M, Yildirim I, Ecevit C, et al. Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey. Int J Infect Dis. 2010; 14: e55-e61
12. Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, et al; Pediatric Prevention Network. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J. 2005; 24: 766-773
13. Hajdu A, Samodova OV, Carlsson TR, et al. A point prevalence survey of hospital-Acquired infections and antimicrobial use in a paediatric hospital in north-western Russia. J Hosp Infect. 2007; 66: 378-384
14. Patel SJ, Oshodi A, Prasad P, et al. Antibiotic use in neonatal intensive care units and adherence with centers for disease control and prevention 12 step campaign to prevent antimicrobial resistance. Pediatr Infect Dis J. 2009; 28: 1047-1051
15. Liem TB, Krediet TG, Fleer A, et al. Variation in antibiotic use in neonatal intensive care units in the Netherlands. J Antimicrob Chemother. 2010; 65: 1270-1275
16. Raveh D, Levy Y, Schlesinger Y, et al. Longitudinal surveillance of antibiotic use in the hospital. QJM. 2001; 94: 141-152
17. Blinova E, Lau E, Bitnun A, et al. Point prevalence survey of antimicrobial utilization in the cardiac and pediatric critical care unit. Pediatr Crit Care Med. 2013; 14: e280-e288
18. Bryant PA. Antimicrobial stewardship resources and activities for children in hospitals in Australasia: a comprehensive survey. Med J Aust. 2015; 202: 134-138
19. Osowicki J, Gwee A, Noronha J, et al. The impact of an infectious diseases consultation on antimicrobial prescribing. Pediatr Infect Dis J. 2014; 33: 669-671
20. Fernando AM, Heath PT, Menson EN. Antimicrobial policies in the neonatal units of the United Kingdom and Republic of Ireland. J Antimicrob Chemother. 2008; 61: 743-745
21. Cotten CM, McDonald S, Stoll B, et al; National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006; 118: 717-722
22. Clark RH, Bloom BT, Spitzer AR, et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics. 2006; 117: 67-74
23. Blayney MP, Al Madani M. Coagulase-negative staphylococcal infections in a neonatal intensive care unit: in vivo response to cloxacillin. Paediatr Child Health. 2006; 11: 659-663
24. Lawrence SL, Roth V, Slinger R, et al. Cloxacillin versus vancomycin for presumed late-onset sepsis in the neonatal intensive care unit and the impact upon outcome of coagulase negative staphylococcal bacteremia: a retrospective cohort study. BMC Pediatr. 2005; 5: 49
25. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics. 2000; 106: 1387-90
26. Brilene T, Soeorg H, Kiis M, et al. In vitro synergy of oxacillin and gentamicin against coagulase-negative staphylococci from blood cultures of neonates with late-onset sepsis. APMIS. 2013; 121: 859-864
27. Clark RH, Bloom BT, Spitzer AR, et al. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics. 2006; 117: 1979-1987
28. Hsieh EM, Hornik CP, Clark RH, et al; Best Pharmaceuticals for Children Act-Pediatric Trials Network. Medication use in the neonatal intensive care unit. Am J Perinatol. 2014; 31: 811-821
29. Kim J, Walker SA, Iaboni DC, et al. Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations. Antimicrob Agents Chemother. 2014; 58: 2830-2840
30. Gwee A, Cranswick N, Metz D, et al. Neonatal vancomycin continuous infusion: still a confusion?. Pediatr Infect Dis J. 2014; 33: 600-605
31. Drysdale SB, Doerholt K, Bielicki J, et al. Poster: a point prevalence survey (PPS) of neonatal antibiotic use in the UK. European Society of Infectious Diseases Annual Conference. Dublin 2014
32. Howell A, Isaacs D, Halliday R; Australasian Study Group For Neonatal Infections. Oral nystatin prophylaxis and neonatal fungal infections. Arch Dis Child Fetal Neonatal Ed. 2009; 94: F429-F433
33. Blyth CC, Barzi F, Hale K, et al. Chemoprophylaxis of neonatal fungal infections in very low birthweight infants: efficacy and safety of fluconazole and nystatin. J Paediatr Child Health. 2012; 48: 846-851
34. Austin N, Darlow BA, McGuire W. Prophylactic oral/topical non-Absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database Syst Rev. 2013; 3: CD003478
35. Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2013; 4: CD003850
36. Kullar R, Goff DA, Schulz LT, et al. The "epic" challenge of optimizing antimicrobial stewardship: the role of electronic medical records and technology. Clin Infect Dis. 2013; 57: 1005-1013
37. Chung GW, Wu JE, Yeo CL, et al. Antimicrobial stewardship: a review of prospective audit and feedback systems and an objective evaluation of outcomes. Virulence. 2013; 4: 151-157